TLR8 signaling could reverse the suppressive functions of tumor-derived CD4+ T cells, CD8+ T cells and γδ regulatory T (Treg) cells resulting in enhanced anti-tumor immunity [50–55]. The gene discussed is CD4; the disease is neoplasm.